Clinical Trial: A Phase II Clinical Study of LT3001 for Injection in the Treatment of Acute Ischemic Stroke

U.S., Aug. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07754825) titled 'A Phase II Clinical Study of LT3001 for Injection in the Treatment of Acute Ischemic Stroke' on Aug. 05.

Brief Summary: This phase II clinical study is designed to evaluate the efficacy and safety of LT3001 in the treatment of acute ischemic stroke

Study Start Date: Sept. 01

Study Type: INTERVENTIONAL

Condition: Acute Ischemic Stroke

Intervention: DRUG: LT3001 Drug:high dose

Drug: LT3001 Drug:high dose Administered by intravenous infusion.

DRUG: LT3001 Drug: low dose

Drug: LT3001 Drug: low dose Administered by intravenous infusion.

DRUG: Placebo

Drug: Placebo Administered by intravenous infusion.

Recruitment Status: NOT_...